MiR-9 Upregulation Leads to Inhibition of Erythropoiesis by Repressing FoxO3
Authors
Affiliations
MicroRNAs (miRNAs) are emerging as critical regulators of normal and malignant hematopoiesis. In previous studies of acute myeloid leukemia miR-9 overexpression was commonly observed. Here, we show that ectopic expression of miR-9 in vitro and in vivo significantly blocks differentiation of erythroid progenitor cells with an increase in reactive oxygen species (ROS) production. Consistent with this observation, ROS scavenging enzymes, including superoxide dismutase (Sod2), Catalase (Cat), and glutathine peroxidase (Gpx1), are down-regulated by miR-9. In addition, miR-9 suppresses expression of the erythroid transcriptional regulator FoxO3, and its down-stream targets Btg1 and Cited 2 in erythroid progenitor cells, while expression of a constitutively active form of FoxO3 (FoxO3-3A) reverses miR-9-induced suppression of erythroid differentiation, and inhibits miR-9-induced ROS production. Thus, our findings indicate that aberrant expression of miR-9 blocks erythropoiesis by deregulating FoxO3-mediated pathways, which may contribute to the ineffective erythropoiesis observed in patients with hematological malignancies.
TFII-I/GTF2I regulates globin gene expression and stress response in erythroid cells.
Nar R, Gibbons M, Perez L, Strouboulis J, Qian Z, Bungert J J Biol Chem. 2025; 301(3):108227.
PMID: 39864622 PMC: 11879681. DOI: 10.1016/j.jbc.2025.108227.
The interactions between ineffective erythropoiesis and ferroptosis in β-thalassemia.
Lin S, Zheng Y, Chen M, Xu L, Huang H Front Physiol. 2024; 15:1346173.
PMID: 38468700 PMC: 10925657. DOI: 10.3389/fphys.2024.1346173.
Insight into microRNAs' involvement in hematopoiesis: current standing point of findings.
Nassiri S, Ahmadi Afshar N, Almasi P Stem Cell Res Ther. 2023; 14(1):282.
PMID: 37794439 PMC: 10552299. DOI: 10.1186/s13287-023-03504-3.
Wang L, Niu Y, He G, Wang J RSC Adv. 2022; 9(28):16158-16166.
PMID: 35521373 PMC: 9064354. DOI: 10.1039/c9ra01544b.
MicroRNAs in the Myelodysplastic Syndrome.
Veryaskina Y, Titov S, Kovynev I, Fedorova S, Pospelova T, Zhimulev I Acta Naturae. 2021; 13(2):4-15.
PMID: 34377552 PMC: 8327150. DOI: 10.32607/actanaturae.11209.